Alimera Sciences (ALIM) Earnings Date, Estimates & Call Transcripts → (Free Workshop) Advanced “bug-out bag” hacks! (From Warrior Life) (Ad) Free ALIM Stock Alerts $3.17 -0.02 (-0.63%) (As of 06/14/2024 08:50 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 14) -$0.12 Missed By -$0.08 Consensus EPS (May. 14) -$0.04 Read Call TranscriptListen to Call Get Alimera Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for ALIM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueALIM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ALIM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIDo you know the 3 golden rules for dividend investing? Would you like a simple set of guidelines for building a rock solid dividend portfolio? Including the two specific tickers I just put $50k into? Well, it’s all included in these FIVE Dividend Cheat SheetsYou can grab your FREE, laminated copies right here Alimera Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.07$0.07$0.07 Q2 20241($0.03)($0.03)($0.03) Q3 20241($0.01)($0.01)($0.01) Q4 20241$0.03$0.03$0.03 FY 20244$0.06$0.06 $0.06ALIM Earnings Date and InformationAlimera Sciences last announced its earnings data on May 14th, 2024. The biopharmaceutical company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.08. The company had revenue of $23.01 million for the quarter, compared to analyst estimates of $23.72 million. Alimera Sciences has generated ($1.57) earnings per share over the last year (($1.57) diluted earnings per share). Earnings for Alimera Sciences are expected to grow in the coming year, from ($0.13) to $0.21 per share. Alimera Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Alimera Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024(Estimated)------- 5/14/2024Q1 2024($0.04)($0.12)($0.08)($0.12)$23.72 million$23.01 million 3/7/2024Q4 2023$0.02($0.07)($0.09)($0.07)$25.10 million$26.31 million 10/26/2023Q3 2023($0.41)($0.06)+$0.35($0.06)$24.40 million$23.36 million8/10/2023Q2 2023$0.06($0.44)($0.50)$0.44$20.36 million$17.54 million5/15/2023Q1 2023($0.58)($0.71)($0.13)($0.71)$13.00 million$13.55 million3/31/2023Q4 2022($0.28)($0.54)($0.26)($0.54)$15.80 million$14.03 million Get the Latest News and Ratings for ALIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alimera Sciences and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Q3 2022($0.37)($0.75)($0.38)($0.75)$15.60 million$13.60 million7/27/2022Q2 2022($0.61)($0.45)+$0.16($0.45)$13.50 million$14.60 million 5/9/2022Q1 2022($0.67)($0.85)($0.18)($0.85)$13.00 million$11.90 million 2/24/2022Q4 2021($0.38)($0.59)($0.21)($0.59)$14.00 million$13.96 million 10/27/2021Q3 2021($0.52)($0.60)($0.08)($0.60)$12.30 million$12.15 million 8/13/2021Q2 2021$1.25$0.76($0.49)$0.49$23.30 million$21.70 million4/27/2021Q1 2021($0.54)($0.63)($0.09)($0.63)$11.60 million$11.21 million 2/23/2021Q4 2020($0.04)($0.18)($0.14)($0.18)$13.00 million$13.77 million 11/2/2020Q3 2020($0.49)($0.12)+$0.37($0.12)$10.75 million$12.47 million 7/29/2020Q2 2020($2.14)($0.51)+$1.63($0.51)$2.30 million$10.04 million 4/29/2020Q1 2020($0.43)($0.24)+$0.19($0.24)$14.04 million$14.54 million 2/26/2020Q4 2019($0.37)$0.08+$0.45$0.08$14.50 million$17.35 million 10/29/2019Q3 2019($0.60)($0.60)-($0.04)$12.75 million$12.85 million 7/29/2019Q2 2019($0.60)($1.05)($0.45)($0.07)$12.97 million$10.86 million Alimera Sciences Earnings - Frequently Asked Questions When is Alimera Sciences's earnings date? Alimera Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on ALIM's earnings history. Did Alimera Sciences beat their earnings estimates last quarter? In the previous quarter, Alimera Sciences (NASDAQ:ALIM) missed the analysts' consensus estimate of ($0.04) by $0.08 with a reported earnings per share (EPS) of ($0.12). Learn more on analysts' earnings estimate vs. ALIM's actual earnings. How can I listen to Alimera Sciences's earnings conference call? The conference call for Alimera Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Alimera Sciences's conference call transcript? The conference call transcript for Alimera Sciences's latest earnings report can be read online. Read Transcript How much revenue does Alimera Sciences generate each year? Alimera Sciences (NASDAQ:ALIM) has a recorded annual revenue of $80.75 million. How much profit does Alimera Sciences generate each year? Alimera Sciences (NASDAQ:ALIM) has a recorded net income of -$20.13 million. ALIM has generated -$1.57 earnings per share over the last four quarters. What is Alimera Sciences's EPS forecast for next year? Alimera Sciences's earnings are expected to grow from ($0.13) per share to $0.21 per share in the next year. More Earnings Resources from MarketBeat Related Companies: ABUS Earnings Date LRMR Earnings Date PHAR Earnings Date PEPG Earnings Date APLT Earnings Date SVRA Earnings Date SIGA Earnings Date ESPR Earnings Date HRTX Earnings Date RNAC Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NASDAQ:ALIM) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alimera Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alimera Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.